According to the MHRA product information, the most frequently reported adverse reactions include: Nausea and vomiting : Very common (affecting more than 1 in 10 people), typically most pronounced during the first 48 weeks of treatment or following dose escalation Diarrhoea : Common (affecting up to 1 in 10 people), with frequency increasing at higher doses Abdominal pain or discomfort : Often described as cramping or bloating sensations Decreased appetite : A direct result of the medication's action on satiety centres Constipation : Less common than diarrhoea but can occur in some individuals Dyspepsia (indigestion) : Characterised by upper abdominal discomfort or burning The timing of these side effects follows a predictable pattern in most patients
That depends on you
doi:10.1016/j.mad.2003.11.005 Huff T, Mller CS, Otto AM, Netzker R, Hannappel E
[66] Despite off-label prescriptions being a normal and legal occurrence in medicine, in 2015 the Drug Enforcement Administration of the US Department of Justice published a position considering off-label prescriptions of HGH to be illegal, and to be a key path for illicit distribution of HGH
PMID: 35952389 EMBO RepLysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness
Confusing mg and mcg: This is the single most common dosing error
.png)
